BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas-Reference-Cited by-同舟云学术

BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas

Published:2013-11-25 Issue:4 Volume:64 Page:547-556
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Bari Muhammad F¹²³,Brown Helen⁴,Nicholson Andrew G⁵,Kerr Keith M⁶,Gosney John R⁷,Wallace William A⁸,Soomro Irshad⁹,Muller Salli¹⁰,Peat Danielle¹¹,Moore Jonathan D¹²,Ward Lesley A⁴,Freidin Maxim B¹³,Lim Eric¹³,Vatish Manu¹⁴,Snead David R J²³

Affiliation:

1. Department of Pathology; Dow International Medical College; Karachi Pakistan

2. Department of Pathology; University Hospitals Coventry and Warwickshire NHS Trust; Coventry UK

3. Divisions of Reproduction and Metabolic and Vascular Health; Warwick Medical School; Coventry UK

4. Department of Life Sciences; University of Warwick; Coventry UK

5. Department of Histopathology; Royal Brompton Hospital and National Heart and Lung Institute; Imperial College; London UK

6. Department of Pathology; Aberdeen Royal Infirmary; Aberdeen UK

7. Department of Pathology; Royal Liverpool University Hospital; Liverpool UK

8. Department of Pathology; Royal Infirmary of Edinburgh; Edinburgh UK

9. Department of Pathology; Nottingham City Hospital; Nottingham UK

10. Department of Pathology; University Hospitals of Leicester; Leicester UK

11. Department of Histopathology; Norfolk and Norwich University Hospital; Norwich UK

12. Warwick Systems Biology Centre; University of Warwick; Coventry UK

13. Department of Thoracic Surgery; Royal Brompton Hospital; London UK

14. Nuffield Department of Obstetrics and Gynaecology; University of Oxford; Oxford UK

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12278/fullpdf

Reference29 articles.

1. Novel strategies for the treatment of small-cell lung carcinoma;William;Nat. Rev. Clin. Oncol.,2011

2. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study;Le Treut;Ann. Oncol.,2013

3. Role of chemotherapy and the receptor tyrosine kinases kit, PDGFRALPHA, PDGFRBETA, and MET in large-cell neuroendocrine carcinoma of the lung;Rossi;J. Clin. Oncol.,2005

4. Reproducibility of neuroendocrine lung tumor classification;Travis;Hum. Pathol.,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma;Frontiers in Medicine;2024-02-27

2. Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer;Oncology Research and Treatment;2023

3. Bisphosphonate-resistant hypercalcemia in a rare case of paraneoplastic PTH secretion;Journal of Clinical and Translational Endocrinology: Case Reports;2022-12

4. Pulmonary Large Cell Neuroendocrine Carcinoma;Pathology and Oncology Research;2022-10-11

5. Adhesion G protein-coupled receptor gluing action guides tissue development and disease;Journal of Molecular Medicine;2022-08-15